Novel Target Study to Cure Cardiovascular Disease regarding Proprotein Converse Subtilisin/Kexin Type 9.

Yingjing ZhaoWeihang LiWeiye LiHong TaoYuting LiBo WuXinhui Wang Huasong Zhou Bo Gao

Published in: BioMed research international (2022)

This study elucidated that ZINC000004099069 and ZINC000014952116 were finally screened as safe and potential drug candidates, which may have great significance in the development of PCSK9 inhibitor development.

Keyphrases

cardiovascular disease
metabolic syndrome
coronary artery disease
risk assessment
oxide nanoparticles
drug induced